Urgent.News

What's breaking now, across thousands of outlets.

Science

Mining fragmented microbial DNA identifies candidates for anticancer testing

Researchers have developed a practical strategy for recovering biosynthetic information from fragmented metagenomic data. Through this work, the researchers identified and prioritized promising natural-product candidates with potential antibacterial or anticancer activity.

Mining fragmented microbial DNA identifies candidates for anticancer testing

Researchers have developed a new method for identifying potential anticancer candidates by mining fragmented microbial DNA. Through this approach, scientists have been able to prioritize natural-product candidates with promising antibacterial or anticancer activity from metagenomic data. Most microorganisms cannot be cultured in the lab, making it challenging to recover biosynthetic gene clusters (BGCs), which are essential for producing these compounds.

The researchers used known, experimentally characterized BGCs as references to help reconstruct fragmented metagenomic data, allowing them to identify candidate pathways and predict bioactive products. They chemically synthesized six selected compounds and tested their biological activity across seven cancer cell lines, finding that compounds D and E exhibited the most potent cytotoxic effects.

This strategy highlights the value of fragmented metagenomic data as a source of hidden biosynthetic information, providing a practical way to explore the chemical potential of uncultured microorganisms and move promising candidates from computational prediction to experimental testing.

Written by urgent.news from Phys.org's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Read the original at phys.org →

More in Science

More from Thursday 1 October →